CHOC and UCI Health’s new designation is expected to attract more resources and recognition to help find novel cures for rare disorders.
Dr. Philip Schwartz
Senior scientist to leave after 26 years with Research Institute positioned for continued growth, success
Dr. Phil Schwartz loves to cook and create new therapies for kids with rare diseases. After 26 years at CHOC, he’s retiring.
CHOC Stem Cell Production Facility to Accelerate Research into Rare Neurological Diseases
CHOC’s new stem cell production facility, slated to open late this summer, will allow CHOC researchers to produce patient-specific cells for immune-matching therapies that could positively impact fatal neurological diseases in children – all at a fraction of the cost of building a larger, more complex laboratory. Within the state-the-art softwall clean room, CHOC researchers […]
Dr. Philip Schwartz Discusses Autism Research
Researchers are studying autism, a brain disease, by turning skin cells into brain cells through genetic manipulation, Philip Schwartz, Ph.D., a senior scientist at CHOC Research Institute, tells “American Health Journal.” Scientists are using these cells with a goal to develop drug therapies for autism, as well as a diagnostic tool for the disorder, Dr. […]
